{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-149336","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2024-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.175276+00:00","generated_at":"2026-06-01T07:35:17.449911+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Acadia shareholders elect directors, approve 2024 equity plan at annual meeting","bullets":["Julian C. Baker, Stephen R. Biggar, and Daniel B. Soland elected as Class II directors.","2024 Equity Incentive Plan approved with 131.3M votes for, 9.4M against.","Say-on-pay advisory vote passed with 132.99M for, 7.64M against.","Ernst & Young ratified as independent auditor for FY2024 with 150.0M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-149336","json":"https://secwatch.observer/filing/0001193125-24-149336.json","markdown":"https://secwatch.observer/filing/0001193125-24-149336.md","text":"https://secwatch.observer/filing/0001193125-24-149336.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312524149336/0001193125-24-149336-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312524149336/d27582d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:35:17.449911+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}